Amrutanjan Health Care Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amrutanjan Health Care Limited with three other companies in this sector in India: Kopran Limited (2018 sales of 3.15 billion Indian Rupees [US$45.70 million] ), Ngl Fine Chem Ltd (1.14 billion Indian Rupees [US$16.50 million] ), and Albert David Limited (2.87 billion Indian Rupees [US$41.74 million] ).

Sales Analysis. During the year ended March of 2018, sales at Amrutanjan Health Care Limited were 2.25 billion Indian Rupees (US$32.63 million). This is an increase of 6.9% versus 2017, when the company's sales were 2.10 billion Indian Rupees. This was the fifth consecutive year of sales increases at Amrutanjan Health Care Limited (and since 2013, sales have increased a total of 73%).